According to a new report by Polaris Market Research, the global Veterinary Renal Disease market was valued at USD 17.79 Billion in 2025 and is projected to reach USD 29.65 Billion by 2034, expanding at a CAGR of 5.90% over the forecast period. Growth is underpinned by rising pet ownership, expanding renal diagnostics, and accelerating adoption of AI-assisted kidney-health monitoring across key end-use segments.

What Is Driving Veterinary Renal Disease Market Growth?

Demand is climbing as rising pet ownership converges with an aging companion-animal population. Veterinarians and pet owners are prioritizing early diagnosis and long-term disease management, pushing veterinary renal disease adoption across diagnostics, medications, and therapeutic diets. Polaris analysts note that chronic kidney disease occurs in about 1–3% of cats according to the International Renal Interest Society, with the percentage rising in older cats, positioning the treatment segment for sustained growth through 2034, with diagnosis emerging as the fastest-growing category as more clinics adopt early testing.

Advancements in veterinary medicine are reinforcing this momentum. Advanced imaging techniques such as ultrasound and CT scans support earlier detection of renal abnormalities, while novel medications, supplements, and therapeutic diets help manage symptoms and preserve kidney function. Heightened pet-owner awareness of preventive healthcare is prompting more proactive veterinary visits, reinforcing early detection and intervention across both feline and canine populations.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/veterinary-renal-disease-market

Key Trends Shaping the Veterinary Renal Disease Industry

AI-Assisted Diagnostics Are Accelerating Early Detection

Artificial intelligence is speeding up urine-sample analysis and enabling continuous monitoring of a pet's health over time, a technology advancement that helps veterinarians identify signs of kidney disease before the condition worsens and supports more personalized treatment planning.

Biomarker Testing Is Reshaping Routine Screening

IDEXX Laboratories' May 2026 addition of the SDMA renal biomarker to its Catalyst chemistry profiles reflects a broader shift in the regulatory and clinical landscape toward earlier, more routine kidney-function screening during standard check-ups.

New Oral Therapies Are Expanding the CKD Treatment Toolkit

Elanco's July 2026 UK launch of Varenzin, a once-daily oral treatment for feline CKD-associated anemia, illustrates a growing market outlook for convenient, long-term oral therapeutics that improve treatment compliance in chronic renal cases.

Market Segmentation: Breaking Down the Veterinary Renal Disease Market

Polaris segments the Veterinary Renal Disease market by type, animal type, route of administration, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Type

The Treatment segment led the market in 2025, accounting for 67.8% of revenue, on the strength of growing demand for long-term disease management through prescription renal diets, medications, and fluid therapy. The Diagnosis segment is projected to expand at the fastest CAGR of 11.5% through 2034 as more clinics adopt early testing to detect kidney disease sooner.

By Animal Type

The Feline segment is expected to grow at the fastest CAGR of 11.2% through 2034, supported by rising global cat ownership, longer feline lifespans, and stronger awareness of age-related kidney health among cat owners. Canine, bovine, and equine populations round out the remaining animal-type demand.

By Route of Administration

Oral administration captured 63.5% of the market in 2025, reflecting its convenience, ease of use, and broad availability across therapeutic renal formulations, making it the preferred choice for long-term treatment compliance in both cats and dogs.

By Disease Type

Chronic Kidney Disease (CKD) and Acute Kidney Injury (AKI) represent the two primary clinical categories addressed by the market, with CKD requiring long-term disease management and AKI requiring immediate medical intervention, shaping distinct diagnostic and treatment protocols across veterinary practices.

Regional Outlook: Where Is Veterinary Renal Disease Growing Fastest?

North America held the largest market share in 2025 at 42.4% of global revenue, supported by high pet ownership and well-established veterinary care infrastructure, while Asia Pacific is expected to post the fastest CAGR of 10.7% through 2034, driven by rising pet ownership and improving veterinary care access across the region. Within North America, the US remains the largest single market; within Asia Pacific, China and India represent significant growth potential as urbanization and disposable incomes rise and Westernized veterinary practices gain broader acceptance.

Competitive Landscape: Leading Veterinary Renal Disease Companies

Key players profiled in the report include Zoetis, IDEXX Laboratories, Elanco Animal Health, Boehringer Ingelheim Animal Health, and Nestle Purina PetCare, who are focusing on new product launches, diagnostic innovation, and portfolio expansion to strengthen market position across the Treatment and Feline segments outlined above. Recent moves include Elanco's July 2026 Varenzin launch for feline CKD-associated anemia and IDEXX's May 2026 integration of the SDMA renal biomarker into its Catalyst chemistry profiles, both aimed at deepening share in the diagnostics and oral-therapeutics categories.

Why It Matters for Animal Health Companies Evaluating Renal-Care Portfolios

For stakeholders researching veterinary renal Disease -care portfolio decisions, this report benchmarks market share, segment-level pricing, and forecast data — by type, animal type, route of administration, and region — to support sourcing, investment, and go-to-market decisions. It is built for animal health companies comparing diagnostic and therapeutic suppliers, investors sizing entry points, and strategy teams tracking early-biomarker diagnostics as a growth adjacency.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

automotive-chassis-structure-design-type

manned-unmanned-teaming-mum-t-market

cleaning-and-hygiene-products-market

small-molecule-cdmo-market

listing-the-top-data-mining-tools-and-techniques-for-powerful-data-analysis

global-insulation-market

autonomous-cars-market

heat-shrink-tubing-and-sleeves-market

playout-automation-and-channel-in-a-box-market